En Thaïlande, la thérapie par cellules souches pour les maladies cardiaques coûte entre $20,000 / 740,000฿ et $35,000 / 1,295,000฿. Le tarif global dépend du nombre de cellules, de la méthode d'administration et du programme choisi. En France, ces interventions avoisinent $37,500 / 1,387,500฿ en moyenne. La Thaïlande permet une économie d'environ 27 %. Les forfaits incluent généralement les consultations, les analyses, l'intervention et le suivi post-opératoire.
Avis d'expert Bookimed : Opter pour un établissement spécialisé comme le Longa Heart Health Medical Center offre une réelle valeur ajoutée. Leurs programmes non invasifs coûtent généralement entre 27 850 € et 37 400 €. C'est un choix judicieux, car ils se consacrent exclusivement à la revitalisation cardiovasculaire. Les cardiologues experts sur place, comme le Dr Ratanapunt Incharoensakdi, possèdent plus de 40 années d'expérience. Ce haut niveau de spécialisation garantit une prise en charge ciblée pour tous les patients cardiaques.
| Thaïlande | Turquie | Espagne | |
| Cellules souches pour les maladies cardiaques | de $20,000 / 740,000฿ | de $16,000 / 592,000฿ | de $30,000 / 1,110,000฿ |
Bookimed ne facture pas de frais supplémentaires pour les prix des Cellules souches pour les maladies cardiaques. Les tarifs sont issus des listes de prix officielles des cliniques. Vous payez directement à la clinique lors de votre arrivée pour votre Cellules souches pour les maladies cardiaques.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans Cellules souches pour les maladies cardiaques et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de Cellules souches pour les maladies cardiaques.
Certifié en médecine régénérative – Le Dr Thongthaisin dirige la thérapie par cellules souches à la Vega Clinic, membre du plus grand groupe hospitalier privé de Thaïlande.
Dr. Piyaphon On-phoon specializes in anti-aging and regenerative medicine. He also provides chelation therapy and immune therapy with high-dose vitamin and nutrition infusions.
He treats erectile dysfunction and offers hormone replacement therapy. He provides preventive care for noncommunicable diseases such as hypertension, atherosclerosis, diabetes, and dyslipidemia. He also treats skin diseases and offers aesthetic procedures using laser, HIFU, Thermage, Botox, and filler injections.
Dr. Sarunyoo Suttipongkeat is trained in cardiology and interventional cardiology. He completed a Clinical Fellowship in Interventional Cardiology (2015–2016) and a Cardiology Fellowship (2013–2015) at the Division of Cardiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
He completed his Internal Medicine residency (2010–2013) and internship (2009–2010) at Buddhachinnaraj Phitsanulok Hospital. He earned his Doctor of Medicine (Second Class Honor) from the Faculty of Medicine Siriraj Hospital, Mahidol University (2002–2009). He studied at Triam Udom Suksa (1998–2002).
Le Dr Karla est spécialisée en cardiologie interventionnelle, ayant suivi sa formation au Département de Cardiologie de l'Hôpital Rajavithi.
Stem cell therapy for heart disease in Thailand carries risks like heart muscle bleeding, immune rejection, and tumour formation. Many treatments are experimental or unregulated, increasing uncertainty about safety and long-term effects. Accredited cardiac centres in Bangkok and Phuket may offer better oversight.
Bookimed Expert Insight: Clinics like The Demarest Clinic use Ministry-sanctioned allogeneic stem cell therapy with controlled lab protocols, showing improved safety. Senior Cardiologist Dr Ratanapunt Incharoensakdi in Bangkok has performed 5,000+ cardiac stem treatments. This shows experienced specialists focus on careful patient selection and oversight. Higher-rated Bangkok centres tend to have established cardiac teams and better success rates.
Patient Consensus: Patients report many Thai stem cell therapies lack scientific proof and may cause serious risks like tumours or immune reactions. Those who chose accredited centres felt safer but stress verifying clinical evidence first. Most recommend consulting a local cardiologist and avoiding treatments outside approved clinical trials.
Stem cell therapy for heart disease in Thailand mainly uses autologous mesenchymal stem cells from fat tissue. Clinics also apply lab-grown umbilical cord and cerebellum-derived mesenchymal stem cells, combined with platelet-rich plasma. These treatments are experimental and not yet proven effective for heart repair.
Bookimed Expert Insight: Most Thai clinics focus on autologous MSCs from fat, as they offer easier harvesting and lower rejection risks. The Demarest Clinic uses Thailand’s first Health Ministry-approved allogeneic stem cell therapy, blending umbilical cord and amniotic MSCs, showing a commitment to research-backed protocols uncommon elsewhere in Thailand.
Patient Consensus: Australian patients find these treatments experimental and urge caution. Most agree traditional cardiology remains best. Stem cell therapy in Thailand is seen as hopeful but unproven, with clinical trials abroad preferred for safer, monitored care.
Stem cells for heart disease in Thailand are mainly given by intravenous (IV) infusion, allowing cells to reach the heart through blood flow. Some clinics experiment with inhalation methods, but IV remains the key delivery approach. This treatment targets regenerating damaged heart tissue with cells from umbilical cord or bone marrow.
Bookimed Expert Insight: Thailand’s stem cell clinics focus on non-invasive IV infusion, making the procedure more accessible. Clinics like The Demarest Clinic in Phuket use AABB-certified cell culture processes and lab-led activation, offering a quality edge. Bangkok's Longa Heart Health Medical Center combines stem cell therapy with heart care innovations, showing rising integration of regenerative and cardiology treatments.
Patient Consensus: Patients recommend checking the exact delivery method and cell type before treatment. Thai centres treat many international patients, with clear communication and cardiologist consultations emphasised for best results.
Stem cell therapy packages for heart disease in Thailand typically include diagnostics, multiple stem cell injections, and hospital monitoring. Clinics often use umbilical cord-derived allogeneic cells prepared over about five days. Treatments may require three sessions with IV or muscular injections, plus specialised follow-up and support.
Bookimed Expert Insight: Thailand’s stem cell centres like The Demarest Clinic lead with allogeneic umbilical cord cells, offering up-to-date protocols and AABB-certified processing. Packages often exclude spinal injections or long hospital stays, so confirming what’s included is key. Bangkok clinics also blend regenerative care with cardiac rehab, giving more holistic recovery options.
Patient Consensus: Patients value Thailand’s advanced cell techniques but advise checking exactly what treatments and sessions are included. Many found treatments took about five days for cell prep, with multiple sessions needed. Australian patients recommend discussing plans with local cardiologists before travel.
Thailand ensures stem cell quality for heart disease through strict regulations, GMP-certified labs, and clinical evaluations. Facilities like The Demarest Clinic use AABB-certified processes for culturing and preserving cells. Ongoing pharmacovigilance tracks treatment safety and effectiveness under Health Ministry oversight.
Bookimed Expert Insight: Clinics with lab certifications like AABB signal better stem cell quality control. The Demarest Clinic in Phuket stands out for using updated global protocols and satellite labs dedicated to cellular treatments, a big plus for Australians wanting reliable regenerative care in Thailand.
Patient Consensus: Australians value treatment transparency and lab standards but warn about scarce public quality control data. Many recommend reviewing peer-reviewed research and discussing stem cell purity with local doctors before travelling to Thailand.
Stem cells for heart disease treatment in Thailand are stored in cryogenic facilities at around -196°C, maintaining their viability for 21 years or longer. Leading clinics and banks in Bangkok and Phuket use liquid nitrogen tanks with strict quality checks to preserve stem cells.
Bookimed Expert Insight: Many Thai centres offering stem cell therapy combine clinical services with direct control over storage, like The Demarest Clinic’s on-site lab in Phuket. This setup ensures fresher cells and tighter quality checks. Australian patients should ask for certification and clinic-specific storage details before booking.
Patient Consensus: Patients say Thai clinics provide professional, carefully monitored stem cell storage. They recommend confirming storage methods and treatment phases, especially since heart disease stem cell therapy can be experimental in Thailand.
Smoking and drinking alcohol are strongly discouraged during stem cell therapy for heart disease in Thailand. Tobacco and alcohol harm stem cell activity and slow healing. This risks the therapy’s success. Most clinics recommend avoiding both at least 48 hours before and 72 hours after treatment.
Bookimed Expert Insight: Thailand’s leading stem cell clinics, like The Demarest Clinic, use up-to-date protocols from global research and strictly control lifestyle factors. Patients gain better results when following pre-treatment restrictions on smoking and alcohol for safer cell engraftment and recovery.
Patient Consensus: Patients in Thailand say avoiding smoking and alcohol helped them heal faster and protect heart function. Many highlight clear clinic instructions and lifestyle tips that supported a smooth recovery process.